Literature DB >> 11244305

Lupus nephritis in children: prognostic significance of clinicopathological findings.

S Emre1, I Bilge, A Sirin, I Kilicaslan, A Nayir, F Oktem, V Uysal.   

Abstract

BACKGROUND: We aimed to review our experience with childhood lupus nephritis (LN) in respect to the analysis of the clinical and histopathological presentation of LN and prognostic factors affecting the kidney and patient outcomes.
METHOD: Forty-three children (39 girls, 4 boys) with biopsy-proven LN were included in the study. The mean age of the children was 12.0 +/- 2.8 years. Based on the renal histopathology and clinical presentation, patients were treated with oral prednisone, intravenous pulses of methylprednisolone or intravenous cyclophosphamide. The final clinical status was classified as follows: (1) renal and extrarenal remission; (2) clinically active renal disease, or (3) adverse outcome, i.e., end-stage renal failure (ESRF) or death.
RESULTS: The mean duration of follow-up was 7.2 +/- 2.8 years (1 month to 14.2 years). All 43 children had hematuria and 53.5% had proteinuria at admission. Fourteen children were in nephrotic status at the onset of disease. Class IV (diffuse proliferative) nephritis was observed in 29 patients as the most frequent histopathology (67.4%). The patients with class IV nephritis had a tendency to develop nephrotic syndrome, heavy proteinuria, increased Cr levels and persistent hypertension at initial evaluation. Thirty-two of 43 children (74.4%) were in renal remission at the last visit. Five-year kidney and patient survival rates from the time of diagnosis to the endpoints of ESRF or death were 83.7 and 90.7% respectively in the whole group while it was 75.9 and 86.2% respectively in the class IV group. Adverse outcome was significantly associated with the persistent hypertension, anemia, high serum Cr level, heavy proteinuria, nephrotic syndrome and class IV nephritis at presentation.
CONCLUSION: We can conclude that the prognosis of LN in children is primarily dependent on the histopathological lesions. Severity of the clinical renal disease at admission and presence of persistent hypertension are the main poor prognostic factors rather than age, gender, low C3 and C4 levels, ANA positivity and the treatment modalities in Turkish children. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244305     DOI: 10.1159/000045899

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  25 in total

1.  Lupus nephritis in Chinese children--a territory-wide cohort study in Hong Kong.

Authors:  Sik-Nin Wong; Kei-Chiu Tse; Tsz-Leung Lee; Kwok-Wai Lee; Stella Chim; Kwok-Piu Lee; Reann Wai-Po Chu; Winnie Chan; Kwok-Wah Fong; Joannie Hui; Samantha Po-Siu Li; Pa-Shing Yeung; So-Fun Yuen; Assunta Chi-Hang Ho; Lettie Chuk-Kwan Leung; David Luk; Pak-Chiu Tong; Shu-Yan Chan; Hon-Ming Cheung; Chung-Mo Chow; David Lau
Journal:  Pediatr Nephrol       Date:  2006-04-26       Impact factor: 3.714

2.  Monozygotic twins concordant for idiopathic thrombocytopenic purpura and discordant for systemic lupus erythematosus and lupus nephritis.

Authors:  Wen-Chin Huang; Shao-Hung Lien; Deh-Ming Chang; Jang-Jih Lu; Shin-Nang Cheng
Journal:  Eur J Pediatr       Date:  2006-09-15       Impact factor: 3.183

3.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

4.  Percutaneous ultrasound-guided renal biopsy in children: a single centre experience.

Authors:  N Printza; J Bosdou; A Pantzaki; M Badouraki; K Kollios; Ch Ghogha; F Papachristou
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

Review 5.  Prevalence and burden of pediatric-onset systemic lupus erythematosus.

Authors:  Sylvia Kamphuis; Earl D Silverman
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

6.  Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis.

Authors:  Stephen D Marks; Vanita Shah; Clarissa Pilkington; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2010-08-05       Impact factor: 3.714

7.  Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children.

Authors:  Keith K Lau; Deborah P Jones; Margaret C Hastings; Lillian W Gaber; Bettina H Ault
Journal:  Pediatr Nephrol       Date:  2006-03-29       Impact factor: 3.714

8.  Lupus nephritis in Egyptian children: a 16-year experience.

Authors:  Atef Elmougy; Amr Sarhan; Ayman Hammad; Ahmed El-Refaey; Mohammed Zedan; Riham Eid; Wafaa Laimon; Wafaa Limon; Ashraf Abd Elrahman; Fatma Elhussieni; Enas El-Sherbeny; Ashraf Bakr
Journal:  J Nephrol       Date:  2014-12-10       Impact factor: 3.902

9.  Outcome of lupus nephritis in Iranian children: prognostic significance of certain features.

Authors:  Neamatollah Ataei; Manijeh Haydarpour; Abbas Madani; Seyed Taher Esfahani; Niloufar Hajizadeh; Mohammad Hasan Moradinejad; Taghi Gholmohammadi; Shahriar Arbabi; Marzieh Haddadi
Journal:  Pediatr Nephrol       Date:  2008-02-13       Impact factor: 3.714

10.  Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Authors:  Radovan Bogdanović; Vesna Nikolić; Srdjan Pasić; Jovan Dimitrijević; Jasmina Lipkovska-Marković; Jelena Erić-Marinković; Milos Ognjanović; Aleksandra Minić; Natasa Stajić
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.